PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2183482
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2183482
The spatial genomics & transcriptomics market is expected to grow from USD 0.67 billion in 2026 to USD 1.23 billion in 2031, at a CAGR of 12.9% during the forecast period. The market is expected to grow steadily, driven by increasing use of spatial profiling in oncology research, precision medicine, drug discovery, biomarker identification, and translational studies. Technologies such as spatial transcriptomics, in situ hybridization, sequencing-based spatial analysis, and high-plex molecular imaging enable the investigation of gene expression, cellular interactions, tissue architecture, and disease mechanisms. These tools support applications across cancer research, therapeutic target identification, treatment-response assessment, neuroscience, immunology, and developmental biology.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2026-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD billion) |
| Segments | Offering, Technique (Products), Type (Services), Application, End User (Products), And End User (Services) |
| Regions covered | North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa |
Growing interest in single-cell analysis, multi-omics integration, and AI-enabled spatial data interpretation is further strengthening adoption across pharmaceutical, biotechnology, academic, clinical research, and CRO settings. In addition, demand for high-resolution instruments, reliable assay kits, validated probes, sequencing reagents, automated sample preparation, and bioinformatics solutions is improving workflow efficiency and data quality.

"Spatial genomics segment to grow at the highest CAGR in the spatial genomics & transcriptomics products market from 2026 to 2031"
By technique, the spatial genomics segment is expected to grow at the highest CAGR during the forecast period, driven by increasing demand for high-resolution analysis of gene expression within intact tissues. Growing applications in oncology, biomarker discovery, drug development, and precision medicine are increasing the need for specialized services that integrate spatial profiling with advanced data analysis. These services help researchers characterize cellular interactions, tissue architecture, and disease-associated molecular patterns, supporting deeper biological insights across pharmaceutical, biotechnology, and academic research settings.
"Sequencing & analytical services segment to hold the largest share of the spatial genomics & transcriptomics services market in 2025"
By type, the sequencing & analytical services segment is likely to account for the largest share of the services market in 2025, driven by the growing need to process and interpret complex spatial molecular data. These services enable researchers to analyze gene expression patterns, identify cellular interactions, and characterize tissue heterogeneity. Increasing applications in oncology, biomarker discovery, drug development, and translational research continue to support demand across pharmaceutical companies, biotechnology firms, and academic research institutes.
"North America to register the second-highest CAGR in the spatial genomics & transcriptomics market between 2026 and 2031"
By region, North America is expected to experience strong market growth during the forecast period, supported by substantial investments in precision medicine, advanced biomedical research infrastructure, and increasing adoption of spatial profiling technologies. Leading companies, including 10x Genomics (US), Illumina, Inc. (US), and Bruker (US), support regional growth through product innovation and platform development. Rising applications in oncology, neuroscience, biomarker discovery, and drug development, alongside pharmaceutical R&D investments and research collaborations, are expected to accelerate technology adoption across the region.
10x Genomics (US), Bio- Techne (US), Bruker (US), Standard BioTools Inc. (US), Illumina, Inc. (US), Bio-Rad Laboratories, Inc. (US), Visiopharm A/S (Denmark), Danaher Corporation (US), Velsera Inc. (US), and Revvity, Inc. (US) are some of the key companies offering spatial genomics & transcriptomics products and services.
Research Coverage
This research report categorizes the spatial genomics & transcriptomics market by offering (products and services), products market by technique (spatial transcriptomics and spatial genomics), services market by type (sample preparation services, sequencing & analytical services, and data visualization & analysis services), application (translational research and drug discovery & development), products market by end user (pharmaceutical & biotechnology companies, academic & research institutes, CROs & CDMOs, and clinical diagnostic laboratories), services market by end user (pharmaceutical & biopharmaceutical companies, academic & research institutes, and other end users), and region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).
The report's scope encompasses detailed information about the primary factors, including drivers, restraints, challenges, and opportunities, that influence the growth of the spatial genomics & transcriptomics market. A comprehensive analysis of key industry players has been performed to provide insights into their business overview, product & service portfolio, key strategies, new product/service launches, acquisitions, and recent developments related to the market. This report also includes a competitive analysis of emerging startups in the spatial genomics & transcriptomics ecosystem.
Key Benefits of Buying the Report
The report will assist market leaders and new entrants by providing revenue estimates for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their businesses effectively and develop suitable go-to-market strategies. This report will enable stakeholders to grasp the market's pulse and offer information on key market drivers, restraints, opportunities, and challenges.